Skip to content

Communication Bridge Speech Therapy Research Study

Communication Bridge Speech Therapy Research Study: Using Internet-Based Speech Therapy to Improve Quality of Life and Access to Care

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02439853
Acronym
CB
Enrollment
57
Registered
2015-05-12
Start date
2013-03-31
Completion date
2020-01-31
Last updated
2024-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Frontotemporal Dementia, Primary Progressive Aphasia

Keywords

primary progressive aphasia, progressive nonfluent aphasia, progressive aphasia, frontotemporal dementia, frontotemporal lobar degeneration

Brief summary

This is a study on Internet-based video-practice speech and language therapy for persons with primary progressive aphasia (PPA), behavioral-variant frontotemporal dementia (bvFTD), or related conditions.

Detailed description

The purpose of this study is: 1. To evaluate the effectiveness of speech and language therapy on a person's ability to communicate immediately after treatment, 6-months after treatment, and 12-months after treatment. 2. To identify the most effective speech and language therapy strategies for persons with these conditions. 3. To determine the feasibility of Internet-based video-practice of speech and language therapy for persons with these conditions. The study will involve 12 to 15 session over the course of 12 months. Some of these sessions will be in-person at the Northwestern Cognitive Neurology and Alzheimer's Disease Center (Chicago, IL), while others will take place over the Internet, using an online study portal.

Interventions

BEHAVIORALMonthly Check-in Session

Subjects in the Check-In group will have an online session with a speech-language pathologist 3-, 4-, and 5-months from the subject's enrollment date.

Sponsors

Alzheimer's Association
CollaboratorOTHER
The Association for Frontotemporal Degeneration
CollaboratorUNKNOWN
Illinois Department of Public Health
CollaboratorOTHER
National Institutes of Health (NIH)
CollaboratorNIH
University of Chicago
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Diagnosis of dementia with language as a primary symptom (i.e. aphasia) * An informant who knows the participant well and can answer questions the participant's communication ability * Adequate hearing to follow conversation (correction permitted) * Adequate vision (correction permitted)

Design outcomes

Primary

MeasureTime frameDescription
Assessment of Functional Communication AbilitiesChange from baseline assessment at 2-months, 6-months and 12-months post-treatmentFunctional Communication Abilities will be assessed through questionnaires about the participant's language and communication, neuropsychological testing, and speech and language therapy evaluations.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026